The Global HIV Prevention Coalition focus countries are progressing unevenly towards the goal of reducing HIV infections to levels that would no longer constitute a public health threat. The biggest declines are occurring in eastern and southern Africa and, to a lesser degree, in western and central Africa. Expansion of access to effective ART, combined with an ongoing focus on primary prevention, are driving those achievements.

In 2024, five years later, the data show that people who inject drugs are still being left behind in the response. In 2022, the global median HIV prevalence among people who inject drugs was 5% across 50 reporting countries, seven times higher than among the rest of the adult population (aged 15–49 years). This figure hides significant geographical and population-based disparities. Among reporting countries, HIV prevalence ranged from 0% to 51%. Among the 16 countries with gender disaggregated data, the reported median HIV prevalence among men who inject drugs was 9%, while it was nearly double (15%) among women who inject drugs.

Remarks by UNAIDS Executive Director at the 67th Session of the Commission on Narcotic Drugs — Vienna, 14 March 2024

The Code of Conduct applies to any UNAIDS event or gathering, which shall include but is not limited to meetings, conferences and symposia, assemblies, receptions, scientific and technical events, expert meetings, workshops, exhibits, side events, and any other forum organized, hosted or sponsored in whole or part by UNAIDS. Such UNAIDS event or gathering, whether it is organized, hosted, or sponsored by UNAIDS, may take place in person or online, within/on or outside UNAIDS premises.